Summary of public comments received on the Draft Screening Assessment for the Protein Derivatives and Yeast Extract Group

Comments on the draft Screening Assessment for the Protein Derivatives and Yeast Extract Group, assessed under the Chemicals Management Plan (CMP), were submitted by a stakeholder.

Summarized public comments and responses are provided below, organized by topic:

Stakeholder engagement and consultation

Summarized comment Summarized response
Stakeholders remain available should further input be required in the finalization of the assessment. Noted.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: